Stay updated on Tolebrutinib in NRSPMS Clinical Trial
Sign up to get notified when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.

Latest updates to the Tolebrutinib in NRSPMS Clinical Trial page
- CheckyesterdayChange DetectedThe page software version was updated from v3.5.4 to v3.5.5, representing a minor release that does not modify the study content or how the page functions for users.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page's revision label has been updated from v3.5.3 to v3.5.4, signaling a small update to the page's underlying content or structure.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision: v3.5.3 now appears on the page, replacing Revision: v3.5.2. This reflects a small, non-substantive update to the page’s documentation/version tag rather than any change to study data, eligibility criteria, or results.SummaryDifference0.0%

- Check44 days agoChange DetectedLocation entries for Gurgaon, India were adjusted for consistent spelling (diacritic removed), leaving the rest of the study details unchanged.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated to v3.5.2. The previous v3.5.0 entry was removed.SummaryDifference0.0%

- Check73 days agoChange DetectedAdded Gūrgaon, India, 122001 and 122002 as site entries with macronized spelling and removed the corresponding plain Gurgaon entries (122001 and 122002); Revision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Tolebrutinib in NRSPMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.